A simple treatment algorithm to aid in the selection of appropriate DMTs reduces racial disparities in patients with ...

Sky-high egg prices have drawn renewed attention to the bird flu outbreak, which has caused more than 166 million wild and ...

With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...

The Food and Drug Administration (FDA) has approved the first generics of Xarelto ® (rivaroxaban) 2.5mg. Xarelto 2.5mg is used, in combination with aspirin, to: Reduce the risk of major cardiovascular ...

One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...

Q4 2024 Earnings Call Transcript March 6, 2025 Operator: Good day, and thank you for standing by. Welcome to the Fourth ...

Key Takeaways DexCom received a warning letter from the Food and Drug Administration following inspections of two of its ...

OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for ...

Sun Pharma will acquire Checkpoint Therapeutics for $355 million, expected to close by Q2 2025. The deal strengthens Sun ...

Sun Pharma has acquired Checkpoint Therapeutics for $355 million, enhancing its onco-dermatology portfolio with the ...

As earnings season begins, filings to the SEC point to uncertainty from the current administration as potential trouble for ...

Zydus Lifesciences Limited received final approval from the U.S. Food and Drug Administration (USFDA) to manufacture ...